01-07-2023 | Myasthenia Gravis | Case report
Immune-globulin/pembrolizumab/prednisone
Myasthenia gravis, rebound effect and lack of efficacy: 2 case reports
Published in: Reactions Weekly | Issue 1/2023
Login to get accessExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event